itraconazole has been researched along with Multiple Myeloma in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 8 (53.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Atsriku, C; Gaudy, A; Liu, L; MacGorman, K; Palmisano, M; Surapaneni, S; Xue, Y; Ye, Y | 1 |
Das, S; Gu, Z; Levasseur, D; Shi, J; Tolomelli, G; Tricot, G; Wang, H; Xia, J; Xu, H; Yang, Y; Zhan, F; Zhou, W; Zhou, Y | 1 |
Eluvathingal, T; Fogel, B; Kothari, A; Mohan, M; Schinke, C | 1 |
Che, FF; Cheng, J; Huang, XB; Shi, Y; Wang, CS; Wang, XD | 1 |
Burgaleta, C; Cuadros, JA; García-Suárez, J; Gómez-Herruz, P; Guillén, H | 1 |
Gu, JL; Huang, BH; Li, J; Liu, JR | 1 |
Fujieda, A; Ishibashi, M; Iwamoto, T; Katayama, N; Masuya, M; Okuda, M | 1 |
Abumiya, M; Kameoka, Y; Miura, M; Sawada, K; Takahashi, N | 1 |
Hashimoto, N; Hattori, Y; Kato, J; Koda, Y; Mori, T; Okamoto, S; Sadahira, K; Shimizu, T; Tsukada, Y; Yamane, A; Yokoyama, K | 1 |
Hashimoto, N; Okamoto, S; Sadahira, K; Tsukada, Y; Ueda, T; Yokoyama, K | 1 |
Alvareda, D; Silva, V; Zepeda, G | 1 |
Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E | 1 |
Gutin, PH; Holodny, A; Prabhakaran, S; Raizer, JJ | 1 |
Asaka, M; Imamura, M; Kahata, K; Kato, N; Ota, S; Tanaka, J; Toubai, T; Toyoshima, N; Umehara, S | 1 |
Ascioglu, S; Casassus, P; De Pauw, B; Denning, DW; Herbrecht, R; Lortholary, O; Marinus, A; Moreau, P | 1 |
1 review(s) available for itraconazole and Multiple Myeloma
Article | Year |
---|---|
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis | 2004 |
1 trial(s) available for itraconazole and Multiple Myeloma
Article | Year |
---|---|
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects.
Topics: Adult; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Healthy Volunteers; Heterocyclic Compounds, 4 or More Rings; Humans; Immunologic Factors; Itraconazole; Lupus Erythematosus, Systemic; Male; Microsomes, Liver; Middle Aged; Morpholines; Multiple Myeloma; Phthalimides; Piperidones; Rifampin; Young Adult | 2021 |
13 other study(ies) available for itraconazole and Multiple Myeloma
Article | Year |
---|---|
RARα2 expression confers myeloma stem cell features.
Topics: Animals; Cell Line, Tumor; Cell Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Isoxazoles; Itraconazole; Mice; Multidrug Resistance-Associated Proteins; Multiple Myeloma; Neoplastic Stem Cells; Plasma Cells; Prognosis; Proto-Oncogene Proteins c-bcl-2; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Signal Transduction; Sulfones; Syndecan-1; Veratrum Alkaloids; Wnt Proteins | 2013 |
Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; beta-Glucans; Colonoscopy; Fever; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Hematopoietic Stem Cell Transplantation; Histoplasma; Histoplasmosis; Humans; Ileum; Intestinal Obstruction; Itraconazole; Lymphadenopathy; Male; Middle Aged; Multiple Myeloma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Weight Loss | 2016 |
[Synergistic Inhibitory Effect of Arsenic Trioxide Combined with Itraconazole on Hedgehog Pathway of Multiple Myeloma NCI-H929 Cells].
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Hedgehog Proteins; Humans; Itraconazole; Mice; Multiple Myeloma; Oxides; Signal Transduction | 2016 |
Rhodotorula mucilaginosa catheter-related fungaemia in a patient with multiple myeloma.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Catheter-Related Infections; Echinocandins; Fungemia; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Multiple Myeloma; Rhodotorula; Treatment Outcome | 2011 |
[The clinical features and risk factors for invasive fungal infection in multiple myeloma.].
Topics: Antifungal Agents; Humans; Itraconazole; Multiple Myeloma; Mycoses; Risk Factors | 2009 |
Drug interaction between itraconazole and bortezomib: exacerbation of peripheral neuropathy and thrombocytopenia induced by bortezomib.
Topics: Adult; Aged; Boronic Acids; Bortezomib; Clinical Trials as Topic; Dexamethasone; Drug Interactions; Female; Humans; Itraconazole; Japan; Male; Middle Aged; Multiple Myeloma; Peripheral Nervous System Diseases; Pyrazines; Retrospective Studies; Secondary Prevention; Thrombocytopenia; Treatment Outcome | 2010 |
Drug interaction between lenalidomide and itraconazole.
Topics: Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dexamethasone; Female; Humans; Intestinal Absorption; Itraconazole; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Prednisone; Thalidomide | 2012 |
[Early onset of paralytic ileus caused by simultaneous administration of bortezomib and azole antifungals in multiple myeloma patients].
Topics: Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Drug Interactions; Drug Therapy, Combination; Humans; Intestinal Pseudo-Obstruction; Itraconazole; Middle Aged; Multiple Myeloma; Mycoses; Pyrazines; Pyrimidines; Triazoles; Voriconazole | 2012 |
Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Cytochrome P-450 Enzyme System; Dexamethasone; Diabetes Complications; Drug Synergism; Female; Humans; Inactivation, Metabolic; Incidence; Itraconazole; Male; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Peripheral Nervous System Diseases; Protease Inhibitors; Proton Pump Inhibitors; Pyrazines; Retrospective Studies; Risk Factors; Salvage Therapy | 2012 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt | 2003 |
Isolated primary intracerebral mycetoma: presenting as a mass lesion in a patient with prostate cancer and multiple myeloma.
Topics: Aged; Amphotericin B; Antifungal Agents; Brain Neoplasms; Central Nervous System Fungal Infections; Diagnosis, Differential; Humans; Itraconazole; Magnetic Resonance Imaging; Male; Mitosporic Fungi; Multiple Myeloma; Mycetoma; Neoplasm Metastasis; Prostatic Neoplasms; Treatment Outcome | 2005 |
[Itraconazole capsules as antifungal prophylaxis for neutropenic patients with hematological malignancies from a single institution].
Topics: Adolescent; Adult; Aged; Capsules; Drug Interactions; Female; Humans; Itraconazole; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Mycoses; Neutropenia; Prospective Studies | 2005 |
Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Europe; Female; Humans; Itraconazole; Male; Middle Aged; Multiple Myeloma; Opportunistic Infections; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2000 |